Rui Shimazaki

Rui Shimazaki

Auto-generated profile, based on publicly available information

Rui Shimazaki

Department of Neuromuscular Research, National Institute of Neuroscience National Center of Neurology and Psychiatry Tokyo Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
RSRui Shimazaki
Rui Shimazaki
MTMarie Tsunogae
Marie Tsunogae
MUMasayuki Ueda
Masayuki Ueda

1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
RSRui Shimazaki
Rui Shimazaki
AUAkinori Uruha
Akinori Uruha
HKHideki Kimura
Hideki Kimura
UNUtako Nagaoka
Utako Nagaoka
TKTomoya Kawazoe
Tomoya Kawazoe
EIEiji Isozaki
Eiji Isozaki
Shimazaki R, et al. J Clin Neurol. 2020 Jul;16(3):510-512. https://doi.org/10.3988/jcn.2020.16.3.510

7 November 2025 in Neuromuscular Disorders
Verified
Journal Article
Closed access
RSRui Shimazaki
Rui Shimazaki
SNSatoru Noguchi
Satoru Noguchi
WYWakako Yoshioka
Wakako Yoshioka
HTHotake Takizawa
Hotake Takizawa
YTYuji Takahashi
Yuji Takahashi
INIchizo Nishino
Ichizo Nishino

18 November 2025 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
RSRui Shimazaki
Rui Shimazaki
SNSatoru Noguchi
Satoru Noguchi
HTHotake Takizawa
Hotake Takizawa
YOYasushi Oya
Yasushi Oya
YTYuji Takahashi
Yuji Takahashi
INIchizo Nishino
Ichizo Nishino
Objectives: Variants in the FHL1 gene cause FHL1‐related myopathies (FHL1‐RMs), a group of neuromuscular disorders with diverse clinical presentations. This study aimed to comprehensively characterize the spatial and temporal patterns of skeletal muscle fat replacement throughout the whole body in FHL1‐RMs, to examine disease progression over time, and to evaluate the relationship between imaging findings and clinical symptoms. Methods: We retrospectively analyzed 21 whole‐body imaging studies from 10 patients with genetically confirmed FHL1‐RMs. Fatty replacement was scored in 47 muscles using the modified Mercuri score (mMS). Longitudinal data were used to stratify patients into slow, moderate, and rapid progression groups. K ‐means clustering was applied to classify muscles based on their chronological patterns of fatty infiltration. Hierarchical clustering and violin plots were used to explore inter‐muscle and inter‐patient variations. Results: Despite notable variability in the rate of disease progression, a consistent pattern of muscle involvement was observed across patients. Muscles were classified into three progression clusters: early‐onset and early attainment of the maximal mMS (e.g., paraspinal and posterior thigh muscles), steadily progressive (e.g., trunk and lower leg muscles), and late‐onset with slow changes (e.g., shoulder and anterior thigh muscles). These patterns paralleled the clinical symptom progression. In early‐stage patients, STIR imaging revealed muscle signal abnormalities preceding fat replacement detectable on T1‐weighted images. Interpretation: The rate of fat replacement in FHL1‐RMs varies individually, but spatial patterns are conserved and reflect clinical evolution. Serial imaging is a valuable tool to monitor disease progression and may serve as a sensitive biomarker in clinical trials.

16 October 2026 in Neuromuscular Disorders
Verified
Journal Article
Closed access
WYWakako Yoshioka
Wakako Yoshioka
SNSatoru Noguchi
Satoru Noguchi
HTHotake Takizawa
Hotake Takizawa
RSRui Shimazaki
Rui Shimazaki
KEKayoko Eguchi
Kayoko Eguchi
INIchizo Nishino
Ichizo Nishino

13 January 2022 in Internal Medicine
Verified
Journal Article
Open access
PDF file
RSRui Shimazaki
Rui Shimazaki
KSKeizo Sugaya
Keizo Sugaya
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.